Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) reported a narrower third-quarter loss, which was worse than analysts had projected. The stock fell close to 5 percent in the extended trade. Net loss was $28.0 million or $0.27 per share, compared to a loss of $39.6 million or $0.39 per share in the prior year. Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) belongs to Healthcare sector. Its weekly performance is -4.81%. On last trading day company shares ended up $8.70. Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) distance from 50-day simple moving average (SMA50) is 7.86%. The Dow Chemical Company (NYSE:DOW)‘s stock had its “neutral” rating reissued by research analysts at JPMorgan Chase & Co. in a report released on Thursday. They currently have a $49.00 price objective on the stock, down from their previous price objective of $50.00. The Dow Chemical Company (NYSE:DOW) shares moved down -0.04% in last trading session and ended the day at $49.48. DOW Gross Margin is 17.60% and its return on assets is 5.20%. The Dow Chemical Company (NYSE:DOW) quarterly performance is -3.81%. On Nov. 5, Pennsylvania Real Estate Investment Trust (NYSE:PEI) announced that it will host "Adventure to Santa – A DreamWorks DreamPlace," at Cherry Hill Mall. The interactive Santa adventure for the entire family is the first-of-its-kind and is set to open to the public on November 28, 2014. On 10 November, Pennsylvania Real Estate Investment Trust (NYSE:PEI) shares increased 1.16% and was closed at $21.73. PEI EPS growth in last 5 year was -1.10%. Pennsylvania Real Estate Investment Trust (NYSE:PEI) year to date (YTD) performance is 18.16%. Balchem Corp. (NASDAQ:BCPC) reported (unaudited) for the period ended September 30, 2014. For the quarter ended September 30, 2014, net sales increased 83.2% to $160.5 million. Balchem Corp. (NASDAQ:BCPC) ended the last trading day at $65.73. Company weekly volatility is calculated as 2.83% and price to cash ratio as 33.67. Balchem Corp. (NASDAQ:BCPC) showed a weekly performance of 4.72%. Ares Commercial Real Estate Corporation (NYSE:ACRE) reported net income of $4.1 million or $0.14 per basic and diluted common share and $15.5 million or $0.54 per basic and diluted common share, respectively, for the three and nine months ended September 30, 2014. Ares Commercial Real Estate Corporation (NYSE:ACRE) shares increased 0.50% in last trading session and ended the day at $12.11. ACRE Gross Margin is 56.80% and its return on assets is 1.80%. Ares Commercial Real Estate Corporation (NYSE:ACRE) quarterly performance is 0.50%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
